TP53 and colorectal carcinoma: In the human CRC cells carrying TP53 mutations, loss of wild-type TP53 by LOH is frequently found4,24, suggesting that the combination of fa TP53 GOF mutation and the subsequent loss of wild-type TP53 is important for the acquisition of a malignant phenotype.